UNSPSC 51131743: Anagrelide hydrochloride monohydrate

This classification denotes the monohydrate form of an antiplatelet agent with the molecular formula C10H7Cl2N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VNS4435G39, chemically known as 6,7-dichloro-1,5-dihydroimidazo(2,1-b)-quinazolin-2(3h)-one monohydrochloride but more generally known as anagrelide hydrochloride, which bears US NIH Compound Identifier 42786. European Medicines Agency schedules Anagrelide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00523MIG.

Most nations, for tariff and trade purposes, schedule anagrelide hydrochloride monohydrate under HS 29335995. As of Q4 2014, ANAGRELIDE HYDROCHLORIDE MONOHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CC(C(C2C1NC3=NC(=O)CN3C2)CL)CL.O.CL.

UNSPSC 51131743 Anagrelide hydrochloride monohydrate is a Commodity code that nominally covers a specific pharmaceutical product — a platelet-reducing agent used in hematologic treatment — yet the recent state and local procurement activity posted under this code does not align with pharmaceutical procurement. The single recent opportunity tagged to this code is Sourcewell RFP #061626, a cooperative purchasing vehicle issued by Sourcewell (a Minnesota local government unit and service cooperative) on behalf of participating entities including Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County in Washington state, along with jurisdictions across the United States and Canada. The RFP solicits law enforcement equipment, a scope wholly unrelated to anagrelide or pharmaceutical supply. This mismatch suggests either a data-entry error in the UNSPSC tagging or a systematic miscoding issue within the Sourcewell portal or the aggregator capturing the notice. No recent opportunities clearly aligned with pharmaceutical procurement or anagrelide distribution appear in the available record.

Given the absence of relevant recent activity under this code, state and local procurement professionals should treat this code as inactive for anagrelide or related pharmaceutical products at present. Sourcewell's RFP #061626 (due June 16, 2026) does establish a law enforcement equipment contracting vehicle available to thousands of governmental agencies, school districts, and public entities across multiple states, but that work falls outside the pharmaceutical space entirely. Verify UNSPSC coding accuracy before treating this code as an active procurement vehicle for pharmaceutical or hematologic products in state and local markets.